These sessions reflect the expert’s clinical approaches based on available evidence and experience. Alternative strategies may be appropriate depending on the patient context.
CAR-T: Optimizing Bridging Therapy and Early Response Rahul Banerjee November 3, 2026
How I Treat Acute GVHD Florent Malard October 26, 2026
Anti-CD38 mAb-based strategies across the myeloma continuum María Victoria Mateos October 21, 2026
MRD-guided treatment decisions: from bench to bedside Rafael Fonseca October 8, 2026
How I Treat Chronic GVHD Florent Malard September 7, 2026
Optimal Managments of other Toxicities Beyond CRS and ICANs with CAR T Cell Therapy Paula Rodríguez Otero June 17, 2026
Optimal Managment of CRS and ICANS with CAR T Cell Therapy Paula Rodríguez Otero May 21, 2026